Pharming Group NV
@PharmingGroupNV
Pharming develops innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs.
HAE-GLO-2021-0008
ID:1397896282027474948
https://www.pharming.com/ 27-05-2021 12:43:58
66 Tweets
320 Followers
0 Following
We are happy to share that Pharming Group NV management will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference and the UBS European Healthcare Conference in the month of February. bit.ly/3HOwHf0
#conference2024 #biopharma #pharminggroup
For Investors and Media: today, Pharming Group NV announces updated full year 2023 guidance and U.S. launch update bit.ly/3TRArDT
The Pharming Group NV management team is in San Francisco this week. Contact [email protected] or [email protected] to schedule a meeting. #JPM2024
Read the interview between Kristie and Tyler and learn more about Tyler’s journey living with #APDS on Behind the Mystery, part of The Balancing Act -a LifeTimeTV program- devoted to advocating for rare and genetic diseases. bit.ly/47gnbfh
#raredisease #pharminggroup
For investors and medical media: Today, Pharming Group NV announces expansion of its rare disease pipeline with plans to develop its PI3K delta inhibitor for additional (PIDs) with immune dysregulation linked to PI3Kẟ signaling. bit.ly/3GHiP5M
#pharminggroup #APDS #PID
The first patient has been dosed in a Phase III pediatric clinical trial evaluating a new oral formulation of our PI3K delta inhibitor in children 1 to 6 years of age who have APDS. Learn more at bit.ly/3MUHlUN
#pharminggroup
Tomorrow our CEO, Sijmen De Vries, will present at the Jefferies London Healthcare Conference at 08:30 GMT/09:30 CET.
#jefferieshealthcare #conferences2023 #biopharma #pharminggroup
Pharming Group NV is pleased to welcome Daniela Dos Anjos Hanova as our new Chief People Officer (CPO) and member of the Executive Committee as of today. For more information please visit our website: bit.ly/3MthLpm
We are happy to share that Pharming Group NV
management will participate in the #Jefferies London Healthcare Conference in the month of November. bit.ly/46OM2XY
To schedule a meeting with management, reach out to [email protected]
#jefferieshealthcare #pharminggroup
This morning Pharming Group NV published its third quarter 2023 financial results. To read the press release please click here: bit.ly/3SeR1N7
Management will hold an analyst & investor call today October 26 at 13:30 CEST/07:30 EDT
#3Q23 #financialresults #pharminggroup
Pharming Group NV will report its 3Q 2023 financial results on Thursday, October 26, 2023, at 07:00 CEST.
We will hold our conference call and webcast at 13:30 CEST/07:30 EDT. Please click on the link for info: bit.ly/3ZQ06xI
#3Q23 #pharminggroup #financialresults
Pharming Group NV reports on the results of the 2023 Extraordinary General Meeting of Shareholders and welcomes Dr. Richard Peters. Please click on the link below to read the press release in full.
bit.ly/3tbzcEs
#EGM2023 #pharminggroup
We are delighted to have been shortlisted in two categories for the Citeline Scrip Awards 2023 for ‘Biotech Company of the Year award' and 'Best New Drug award'! For more information visit: bit.ly/3rrN2BO
#shortlist #biopharma #ScripAwards